Boston Scientific Corp Stock Analysis
BSX Stock | USD 100.69 0.82 0.81% |
Boston Scientific Corp is overvalued with Real Value of 88.31 and Target Price of 99.42. The main objective of Boston Scientific stock analysis is to determine its intrinsic value, which is an estimate of what Boston Scientific Corp is worth, separate from its market price. There are two main types of Boston Scientific's stock analysis: fundamental analysis and technical analysis.
The Boston Scientific stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Boston Scientific is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Boston Stock trading window is adjusted to America/New York timezone.
Boston |
Boston Stock Analysis Notes
About 93.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.98. Boston Scientific Corp had not issued any dividends in recent years. The entity had 2:1 split on the 6th of November 2003. Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. Boston Scientific operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 41000 people. For more info on Boston Scientific Corp please contact Michael Mahoney at 508 683 4000 or go to https://www.bostonscientific.com.Boston Scientific Quarterly Total Revenue |
|
Boston Scientific Corp Investment Alerts
Boston Scientific is unlikely to experience financial distress in the next 2 years | |
Over 93.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from zacks.com: PODD Stock Gains Following the Launch of Omnipod 5 in Australia |
Boston Scientific Corp Upcoming and Recent Events
Earnings reports are used by Boston Scientific to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
31st of January 2024 Upcoming Quarterly Report | View | |
24th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
31st of January 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Boston Largest EPS Surprises
Earnings surprises can significantly impact Boston Scientific's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2013-10-24 | 2013-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2013-04-25 | 2013-03-31 | 0.09 | 0.1 | 0.01 | 11 | ||
2012-07-26 | 2012-06-30 | 0.1 | 0.11 | 0.01 | 10 |
Boston Scientific Environmental, Social, and Governance (ESG) Scores
Boston Scientific's ESG score is a quantitative measure that evaluates Boston Scientific's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Boston Scientific's operations that may have significant financial implications and affect Boston Scientific's stock price as well as guide investors towards more socially responsible investments.
Boston Scientific Thematic Classifications
In addition to having Boston Scientific stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | HealthcareUSA Equities from Healthcare industry as classified by Fama & French | |
![]() | Obamacare RepealLarge healthcare related equities associated with Obamacare |
Boston Stock Institutional Investors
Shares | Bollard Group Llc | 2024-12-31 | 20.7 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 20.5 M | Norges Bank | 2024-12-31 | 19.7 M | Massachusetts Financial Services Company | 2024-12-31 | 19.7 M | Franklin Resources Inc | 2024-12-31 | 16.5 M | Amvescap Plc. | 2024-12-31 | 15.8 M | Hhg Plc | 2024-12-31 | 15 M | Northern Trust Corp | 2024-12-31 | 14.6 M | Goldman Sachs Group Inc | 2024-12-31 | 12.9 M | Blackrock Inc | 2024-12-31 | 139 M | Vanguard Group Inc | 2024-12-31 | 132.9 M |
Boston Market Capitalization
The company currently falls under 'Mega-Cap' category with a total capitalization of 148.93 B.Boston Profitablity
The company has Net Profit Margin of 0.11 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.17 %, which entails that for every 100 dollars of revenue, it generated $0.17 of operating income.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.12 | 0.12 | |
Return On Capital Employed | 0.08 | 0.13 | |
Return On Assets | 0.05 | 0.05 | |
Return On Equity | 0.09 | 0.07 |
Management Efficiency
Boston Scientific Corp has Return on Asset of 0.0504 % which means that on every $100 spent on assets, it made $0.0504 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0889 %, implying that it generated $0.0889 on every 100 dollars invested. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Boston Scientific's Return On Tangible Assets are fairly stable compared to the past year. Return On Capital Employed is likely to rise to 0.13 in 2025, whereas Return On Equity is likely to drop 0.07 in 2025. At this time, Boston Scientific's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 34.1 B in 2025, whereas Intangible Assets are likely to drop slightly above 5 B in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 14.95 | 15.70 | |
Tangible Book Value Per Share | (1.20) | (1.26) | |
Enterprise Value Over EBITDA | 54.46 | 57.19 | |
Price Book Value Ratio | 6.04 | 5.90 | |
Enterprise Value Multiple | 54.46 | 57.19 | |
Price Fair Value | 6.04 | 5.90 | |
Enterprise Value | 61.2 B | 64.2 B |
Leadership at Boston Scientific emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Technical Drivers
As of the 23rd of March, Boston Scientific shows the Downside Deviation of 1.76, risk adjusted performance of 0.1138, and Mean Deviation of 0.99. Boston Scientific Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Boston Scientific Corp Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Boston Scientific middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Boston Scientific Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Boston Scientific Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Boston Scientific insiders, such as employees or executives, is commonly permitted as long as it does not rely on Boston Scientific's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Boston Scientific insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Joseph Fitzgerald over a month ago Acquisition by Joseph Fitzgerald of 60 shares of Boston Scientific subject to Rule 16b-3 | ||
Joseph Fitzgerald over three months ago Disposition of 11236 shares by Joseph Fitzgerald of Boston Scientific subject to Rule 16b-3 | ||
Arthur Butcher over three months ago Disposition of 14010 shares by Arthur Butcher of Boston Scientific at 89.2694 subject to Rule 16b-3 | ||
Wendy Carruthers over six months ago Disposition of 1197 shares by Wendy Carruthers of Boston Scientific at 24.55 subject to Rule 16b-3 | ||
Wendy Carruthers over six months ago Disposition of 6983 shares by Wendy Carruthers of Boston Scientific at 66.89 subject to Rule 16b-3 | ||
Daniel Brennan over a year ago Disposition of 1644 shares by Daniel Brennan of Boston Scientific at 65.82 subject to Rule 16b-3 | ||
Tobin James R over a year ago Exercise or conversion by Tobin James R of 100000 shares of Boston Scientific subject to Rule 16b-3 |
Boston Scientific Outstanding Bonds
Boston Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Boston Scientific Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Boston bonds can be classified according to their maturity, which is the date when Boston Scientific Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
BOSTON PPTYS LTD Corp BondUS10112RAY09 | View | |
BOSTON PPTYS LTD Corp BondUS10112RAX26 | View | |
BXP 675 01 DEC 27 Corp BondUS10112RBG83 | View | |
BOSTON SCIENTIFIC P Corp BondUS101137AL15 | View | |
BXP 245 01 OCT 33 Corp BondUS10112RBF01 | View | |
BOSTON PROPERTIES LP Corp BondUS10112RBE36 | View | |
BOSTON PROPERTIES LP Corp BondUS10112RBD52 | View |
Boston Scientific Predictive Daily Indicators
Boston Scientific intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Boston Scientific stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Boston Scientific Corporate Filings
19th of March 2025 Other Reports | ViewVerify | |
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 3rd of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 26th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 25th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 24th of February 121225 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
21st of February 2025 Other Reports | ViewVerify | |
F4 | 19th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Boston Scientific Forecast Models
Boston Scientific's time-series forecasting models are one of many Boston Scientific's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Boston Scientific's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Boston Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Boston Scientific prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Boston shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Boston Scientific. By using and applying Boston Stock analysis, traders can create a robust methodology for identifying Boston entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.14 | 0.14 | |
Operating Profit Margin | 0.16 | 0.10 | |
Net Profit Margin | 0.11 | 0.12 | |
Gross Profit Margin | 0.69 | 0.77 |
Current Boston Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Boston analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Boston analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
99.42 | Strong Buy | 34 | Odds |
Most Boston analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Boston stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Boston Scientific Corp, talking to its executives and customers, or listening to Boston conference calls.
Boston Stock Analysis Indicators
Boston Scientific Corp stock analysis indicators help investors evaluate how Boston Scientific stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Boston Scientific shares will generate the highest return on investment. By understating and applying Boston Scientific stock analysis, traders can identify Boston Scientific position entry and exit signals to maximize returns.
Begin Period Cash Flow | 1.1 B | |
Long Term Debt | 8.8 B | |
Common Stock Shares Outstanding | 1.5 B | |
Total Stockholder Equity | 21.8 B | |
Tax Provision | 436 M | |
Quarterly Earnings Growth Y O Y | 0.12 | |
Property Plant And Equipment Net | 3.3 B | |
Cash And Short Term Investments | 414 M | |
Cash | 414 M | |
Accounts Payable | 960 M | |
Net Debt | 10.3 B | |
50 Day M A | 101.3848 | |
Total Current Liabilities | 6.4 B | |
Other Operating Expenses | 14.1 B | |
Non Current Assets Total | 32.5 B | |
Forward Price Earnings | 35.3357 | |
Non Currrent Assets Other | 1.8 B | |
Stock Based Compensation | 266 M |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.